Clinical Significance of the Humoral Immune Response to Modified LDL

  • Tsiantoulas D
  • Diehl C
  • Witztum J
 et al. 
  • 5


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


Oxidation of low-density lipoprotein (LDL) has a key role in atherogenesis. Among the different models of oxidation that have been studied, the one using myeloperoxidase (MPO) is thought to be more physiopathologically relevant. Apolipoprotein B-100 is the unique protein of LDL and is the major target of MPO. Furthermore, MPO rapidly adsorbs at the surface of LDL, promoting oxidation of amino acid residues and formation of oxidized lipoproteins that are commonly named Mox-LDL. The latter is not recognized by the LDL receptor and is accumulated by macrophages. In the context of atherogenesis, Mox-LDL accumulates in macrophages leading to foam cell formation. Furthermore, Mox-LDL seems to have specific effects and triggers inflammation. Indeed, those oxidized lipoproteins activate endothelial cells and monocytes/macrophages and induce proinflammatory molecules such as TNF alpha and IL-8. Mox-LDL may also inhibit fibrinolysis mediated via endothelial cells and consecutively increase the risk of thrombus formation. Finally, Mox-LDL has been involved in the physiopathology of several diseases linked to atherosclerosis such as kidney failure and consequent hemodialysis therapy, erectile dysfunction, and sleep restriction. All these issues show that the investigations of MPO-dependent LDL oxidation are of importance to better understand the inflammatory context of atherosclerosis.

Author-supplied keywords

  • Anti-oxLDL antibodies
  • Antibodies
  • Atherogenesis
  • Atherosclerosis
  • B cell
  • B cells
  • B-lymphocytes
  • Cardiovascular disease
  • Dendritic cells
  • Endothelium
  • Inflammation
  • LDL
  • LDL antibodies
  • Lipoprotein(a)
  • Passive immunization
  • Pathophysiology
  • Proteins
  • T cells
  • T-lymphocytes
  • Therapy
  • Tumor-growth
  • adaptive immunity
  • antibodies
  • antibody ⅲ inflammation ⅲ
  • atherosclerosis
  • autoantibodies
  • autoimmunity
  • b cells
  • b-lymphocytes
  • cardiovascular disease
  • complement system proteins
  • cytokines
  • humoral
  • hypercholesterolemia
  • immune cells
  • immune modulation
  • immunity
  • immunomodulation
  • immunopathology
  • inflammation
  • innate
  • lipoproteins
  • lymphocytes ⅲ macrophages ⅲ
  • modified LDL
  • myocardial infarction
  • natural antibodies
  • oxidized
  • pathophysiology
  • rituximab
  • stroke
  • therapy
  • thrombosis

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in


  • Dimitrios Tsiantoulas

  • Cody J Diehl

  • Joseph L Witztum

  • Christoph J Binder

  • Evelyn Orsó

  • Gerd Schmitz

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free